- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-06-0001421

Chevron Pharma Private Limited
About Chevron Pharma Private Limited
Data last updated:
Chevron Pharma Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2010PTC061749. Its GSTIN is 24AAECC0898H1ZM (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹45 Lakh. It is led by directors including Harshaben Mahesh Jakasaniya and Umesh Mavjibhai Mendapara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6505 GIDC Estate, Ankleshwar, Gujarat, India – 392001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.69 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹54.6 Lakh (net margin 5.6%) and EBITDA of ₹1.49 Cr (EBITDA margin 15.4%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 15% over five years.
The company has about 57 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹13.94 Cr on record.
Chevron Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0001421). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Chevron Pharma
Contact details
Chevron Pharma Private Limited's registered office is in Ankleshwar, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address6505 GIDC Estate, Ankleshwar, Gujarat, India – 392001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Chevron Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chevron Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Chevron Pharma Private Limited, buy the company report.
Financials of Chevron Pharma Private Limited
FY 2025 filings availableChevron Pharma Private Limited reported revenue of ₹9.69 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 33% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 15%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chevron Pharma Private Limited, buy the company report.
Board of directors of Chevron Pharma Private Limited
Chevron Pharma has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshaben Mahesh Jakasaniya | Director | 01 May 2019 | 7 Years 5 Months | Current |
| Umesh Mavjibhai Mendapara Also directs: Amsal-Chem Private Limited, Apex Healthcare Limited, Mendas Pharma Private Limited and 3 more | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Karan Maheshkumar Jakasaniya | Director | 19 Mar 2018 | 8 Years 7 Months | Current |
| Pravin Samatbhai Teraiya | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Uramilaben Pravinbhai Teraiya | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Rameshbhai Devjibhai Gabani Also directs: Amsal-Chem Private Limited, Apex Healthcare Limited, Ankleshwar Research and Analytical Infrastructure Association and 1 more | Director | 27 Jul 2010 | 16 Years 2 Months | Current |
Peer comparison
Chevron Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Labinduss Limited | ₹9.73 Cr (FY 2025) | 27.0% | Palghat, Kerala, India | |||
| Harson Laboratories India Private Limited | ₹9.71 Cr (FY 2025) | 38.0% | Vadodara, Gujarat, India | |||
| Chevron Pharma Private Limitedthis company | ₹9.69 Cr (FY 2025) | ₹54.6 Lakh | 5.6% | 33.0% | 57 | Ankleshwar, Gujarat, India |
| Uni-Labs (India) Private Limited | ₹9.68 Cr (FY 2024) | -8.0% | Tamil Nadu, India | |||
| Prabhat Chemiorganics Limited | ₹9.65 Cr (FY 2025) | 48.0% | Dahisar, Mumbai-68, Maharashtra, India |
To see the full peer comparison of Chevron Pharma Private Limited, buy the company report.
Auditor
Chevron Pharma Private Limited is audited by K K HARYANI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K K HARYANI & CO | FY 2023 | 121950W |
Shareholding
The shareholding of Chevron Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chevron Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 May 2018 | 100178668 | Axis Bank Limited | ₹4.72 Cr | Satisfied | |
| 06 Mar 2018 | 100162255 | Axis Bank Limited | ₹4.72 Cr | Satisfied | |
| 08 Jun 2015 | 10578818 | Bank of Baroda | ₹1.5 Cr | Satisfied | |
| 13 Mar 2015 | 10555137 | Bank of Baroda | ₹1.5 Cr | Satisfied | |
| 02 Aug 2011 | 10302924 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Chevron Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Chevron Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chevron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Chevron Pharma Private Limited has a workforce of 57 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Chevron Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECC0898H1ZM | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chevron Pharma Private Limited, buy the company report.
Recent activity
Chevron Pharma Private Limited has 11 board changes on record since 2010: 6 appointments and 5 cessations. The latest: Harshaben Mahesh Jakasaniya was appointed as Director on 01 May 2019.
14 earlier events are in the company report.
Frequently asked questions
Chevron Pharma is an active private limited company based in Ankleshwar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2010 (16+ years old) and is registered under CIN U24100GJ2010PTC061749.
Chevron Pharma has 6 current directors:
- Harshaben Mahesh Jakasaniya - Director
- Umesh Mavjibhai Mendapara - Director
- Karan Maheshkumar Jakasaniya - Director
- Pravin Samatbhai Teraiya - Director
- Uramilaben Pravinbhai Teraiya - Director
- Rameshbhai Devjibhai Gabani - Director
The latest financial statements of Chevron Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Chevron Pharma is 24AAECC0898H1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Chevron Pharma is U24100GJ2010PTC061749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chevron Pharma was incorporated on 27 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Chevron Pharma by revenue are Labinduss Limited, Harson Laboratories India Private Limited, Uni-Labs (India) Private Limited, Prabhat Chemiorganics Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harshaben Mahesh Jakasaniya was appointed as Director on 01 May 2019. Maheshkumar Rugnathbhai Jakasaniya ceased to be Director on 14 Apr 2019. Karan Maheshkumar Jakasaniya was appointed as Director on 19 Mar 2018. Chevron Pharma has 11 board changes on record in total.
Yes, Chevron Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-06-0001421).
The registered office of Chevron Pharma is at 6505 GIDC Estate, Ankleshwar, Gujarat, India – 392001.
Chevron Pharma operates in the pharma industry, in the drug formulation and development segment.